SKIN AND SOFT PARTS INFECTION, TREATMENT IN THE PEDIATRIC AGE
Article Sidebar
Main Article Content
Abstract
Introduction: Skin and soft tissue infection is one of the common infections in the pediatric population. The frequent etiological agents are Streptococcus pyogenes and Staphylococcus aureus, which can be methicillin sensitive and methicillin resistant, which, when treated inadequately, cause therapeutic failures or failures, developing bacterial resistance. Objective: Identify the etiological agents that cause skin and soft tissue infection, as an updated therapeutic management in the pediatric population treated in a tertiary hospital. Method: A descriptive observational cross-sectional study was carried out on hospitalized patients who presented skin and soft tissue infections admitted to the Infectious Diseases service of the Baca Ortiz Pediatric Hospital in the period between August 2015 - August 2016. Results: Clinical presentations common were cellulitis, erysipelas, impetigo, abscess; affected gender male; Due to its location, it occurred in the extremities and periorbital region; empirical antibiotic therapy treatment based on beta-lactams and if there was skin laceration, clindamycin was added; if there was suspicion of resistance, fifth-generation cephalosporins or new non-fluorinated quinolones were administered. Conclusion: The isolated etiological agents were streptococcus pyogenes, methicillin-sensitive and resistant staphylococcus; the initial treatment was based on empirical antibiotic therapy to reduce hospital stay and prevent systemic complications, with a therapy time of 5 to 7 days according to the latest evidence, if there was no response to treatment in 48 to 72 hours, antibiotics were immediately rotated not as simple monotherapy but as bi or tritherapy
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Ensinck GN, Casanueva E, Sguassero Y, Moyano M, Peuchot A, Giachetti AC, et al. Infecciones de piel y partes blandas en pediatría: Consenso sobre diagnóstico y tratamiento. Arch Argent Pediatr. 2014;12(2):183–91.
Yueh CM, Chi H, Chiu NC, Huang FY, Tsung-Ning Huang D, Chang L, et al. Etiology, clinical features, management, and outcomes of skin and soft tissue infections in hospitalized children: A 10-year review. J Microbiol Immunol Infect [Internet]. 2022;55(4):728–39. Available from: https://doi.org/10.1016/j.jmii.2022.01.007
Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infect Drug Resist. 2018;11:1959–74.
Cunto ER, Colque ÁM, Herrera MP, Chediack V, Staneloni MI, Saúl PA. Infecciones Graves De Piel Y Partes Blandas. Puesta Al Día. Medicina (B Aires). 2020;80(5):531–40. https://www.medicinabuenosaires.com/indices-de-2020/volumen-80-ano-2020-no-5-indice/infecciones_graves/
Boettler MA, Kaffenberger BH, Chung CG. Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis. Vol. 23, American Journal of Clinical Dermatology. Adis; 2022. p. 153–65. doi: 10.1007/s40257-021-00659-8.
Principi N, Argentiero A, Neglia C, Gramegna A, Esposito S. New antibiotics for the treatment of acute bacterial skin and soft tissue infections in pediatrics. Pharmaceuticals. 2020;13(11):1–14. doi: 10.3390/ph13110333
Stevens DL, Bryant AE. Streptococcus pyogenes Impetigo, Erysipelas, and Cellulitis. 2022 Oct 4 [cited 2023 Feb 15]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK587091/
Lipsett SC, Monuteaux MC, Fine AM. Seasonality of Common Pediatric Infectious Diseases. Pediatr Emerg Care. 2021;37(2):82–5. doi: 10.1097/PEC.0000000000001496.
Arıkan K, Karadag-Oncel E, Aycan AE, Yuksekkaya S, Sancak B, Ceyhan M. Epidemiologic and molecular characteristics of Staphylococcus aureus strains isolated from hospitalized pediatric patients. Pediatr Infect Dis J. 2020;39(11):1002–6. doi: 10.1097/INF.0000000000002764.
Salleo E, MacKay CI, Cannon J, King B, Bowen AC. Cellulitis in children: A retrospective single centre study from Australia. BMJ Paediatr Open. 2021;5(1):1–8. doi:10.1136/bmjpo-2021-001130
Shih EJ, Chen JK, Tsai PJ, Lin MC, Bee YS. Antibiotic Choices for Pediatric Periorbital Cellulitis—A 20-Year Retrospective Study from Taiwan. Antibiotics. 2022;11(10):1–12. doi: 10.3390/antibiotics11101288.
Zajac-Spychala O, Wachowiak J, Gryniewicz-Kwiatkowska O, Gietka A, Dembowska-Baginska B, Semczuk K, et al. Prevalence, Epidemiology, Etiology, and Sensitivity of Invasive Bacterial Infections in Pediatric Patients Undergoing Oncological Treatment: A Multicenter Nationwide Study. Microb Drug Resist. 2021;27(1):53–63. doi: 10.1089/mdr.2019.0393.
Alizai Q, Haseeb A, Hamayun S, Khan S, Ali F, Roghani M, et al. Community-Acquired Skin and Soft Tissue Infections: Epidemiology and Management in Patients Presenting to the Emergency Department of a Tertiary Care Hospital. Cureus [Internet]. 2023 Jan 30 [cited 2023 Feb 15];15(1). Available from: https://www.cureus.com/articles/133509-community-acquired-skin-and-soft-tissue-infections-epidemiology-and-management-in-patients-presenting-to-the-emergency-department-of-a-tertiary-care-hospital. doi: 10.7759/cureus.34379.
Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common Community-acquired Bacterial Skin and Soft-tissue Infections in Children: an Intersociety Consensus on Impetigo, Abscess, and Cellulitis Treatment. Clin Ther. 2019;41(3):532-551.e17. doi: 10.1016/j.clinthera.2019.01.010.
Lopez DM, Cervantes BYH, Emmanuel D, Agordoh PD, Almaguer FM, Lambert RG, et al. Infections of the Skin among Children in Ho Teaching Hospital of the Volta Region, Ghana. OALib. 2020;07(03):1–9. DOI: 10.4236/oalib.1106192
Bartoszko JJ, Mertz D, Thabane L, Loeb M. Antibiotic therapy for skin and soft tissue infections: a protocol for a systematic review and network meta-analysis. Available from: https://doi.org/10.1186/s13643-018-0804-8
Baquero-Artigao F, Ramos JT, Cercenado E, Rodrigo C, Saavedra-Lozano J, Soler-Palacín P, et al. Documento de posicionamiento de la Asociación Española de Pediatría-Sociedad Española de Infectología Pediátrica sobre el tratamiento de las infecciones por bacterias multirresistentes. Rev Latinoam Infectología Pediátrica. 2020;33(1):7–18. DOI: 10.1016/j.anpedi.2019.08.002
Whitney E. Antibiotic stewardship–Basic principles in urinary tract infections, community acquired pneumonia, and skin and soft tissue infections. Curr Probl Pediatr Adolesc Health Care [Internet]. 2021;51(4):101002. Available from: https://doi.org/10.1016/j.cppeds.2021.101002
Principi N, Argentiero A, Neglia C, Gramegna A, Esposito S. pharmaceuticals New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics. Available from: www.mdpi.com/journal/pharmaceuticals.https://doi.org/10.3390/ph13110333
Stagnaro JP, Lisarrague S, Bernstein JC, Schell C, Fortunato E, Santolin C, et al. Características clínicas y microbiológicas de infecciones de piel y partes blandas en pacientes pediátricos de dos hospitales de Buenos Aires. Actual en Sida e Infectología. 2022;7–16. https://doi.org/10.52226/revista.v30i108.109
Parrish KL, Salwan NK, Thompson RM, Hogan PG, Orscheln RC, Newland JG, et al. Skin and Soft Tissue Infection Treatment and Prevention Practices by Pediatric Infectious Diseases Providers. J Pediatric Infect Dis Soc. 2020;9(6):760–5. doi: 10.1093/jpids/piz080.
Hopkins J, Children ALL. Pediatric skin and soft tissue infections: Clinical practiceOsmosis.Availablefrom:https://www.osmosis.org/learn/Pediatric_skin_and_soft_tissue_infections:_Clinical_practice.doi:10.1093/jpids/piz080.
Mupirocina | Asociación Española de Pediatría [Internet]. [cited 2023 Feb 16]. Available from: https://www.aeped.es/comite-medicamentos/pediamecum/mupirocina
Pong Id S, Fowler RA, Murthy S, Pernica Id JM, Gilfoyle E, Fontela P, et al. Antibiotic treatment duration for bloodstream infections in critically ill children-A survey of pediatric infectious diseases and critical care clinicians for clinical equipoise. 2022; Available from: https://doi.org/10.1371/journal.pone.0272021
Gillet Y, Lorrot M, Cohena R, Hau I, Grimprel E, Gras-Le Guen C. Antibiotic treatment of skin and soft tissue infections. Arch Pediatr [Internet]. 2017;24(12):S30–5. Available from: http://dx.doi.org/10.1016/S0929-693X(17)30516-X
Brandt ML, Berg SL. Skin and soft-tissue infections in children. Semin Pediatr Infect Dis. 1996;7(1):35–41. doi: 10.5546/aap.2014.96.
Angeles-R. MC, Morales-J. AC, Yacarini-M. AE. Resistencia a los antibióticos: Agravamiento en la situación de salud pública. Rev del Cuerpo Médico del HNAAA. 2020;13(1):99–100. DOI: https://doi.org/10.35434/rcmhnaaa.2020.131.632.
Mestrovic T, Robles Aguilar G, Swetschinski LR, Ikuta KS, Gray AP, Davis Weaver N, et al. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Heal. 2022;7(11):e897–913. doi: 10.1016/S2468-2667(22)00225-0.
Impacto EL, Pandemia DELA. Superbacterias en tiempos de covid-19. 2016; https://metode.es/revistas-metode/article-revistes/superbacterias-en-tiempos-de-covid-19.html.
Treviño NP, Molina NB. Antibióticos: mecanismos de acción y resistencia bacteriana. Mater cátedra Corresp a la Cl Gen Bacteriol [Internet]. 2022;(figura 1):1–9. Available from: http://sedici.unlp.edu.ar/handle/10915/136280
Bouza E, Giuseppe F, Aneta DR, Dirschka T, Pellacani G. Multidisciplinary panel opinion on the management of bacterial skin infections. 2022;(May):165–75. https://doi.org/10.1002/jvc2.43.
Aureus S, Hogan PG, Rodriguez M, Spenner AM, Brenneisen JM, Boyle MG, et al. Clinical Infectious Diseases Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection. Colon After Antibiot • CID [Internet]. 2018:66. Available from: https://academic.oup.com/cid/article/66/2/191/4093094. DOI: 10.1093/cid/cix754